Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : PJ December 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Xalkori approved for first-line use Subscription

    17 DEC 2015 15:50

    The European Commission has approved the use of Xalkori (crizotinib; Pfizer) for the first-line treatment of adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer. The drug was previously only licensed for second-line treatment. 

  • Ventmax discontinued Subscription

    17 DEC 2015 15:40

    Ventmax (salbutamol; Chiesi) SR 4mg capsules are no longer in the supply chain and the expiry date of the last stock supplied was 30 November 2015. Ventmax SR 8mg capsules are also being discontinued.

  • In the image, a pharmacy-based robot that takes blisters of medicines and repackages them into individual bar coded envelopes. This new system has streamlined the work of nurses at the renal ward of the University Hospital of Leicester

    Unit-dose drug system frees up nurses and ‘removes potential for error’ Subscription

    14 DEC 2015 16:42 By Christine Clark

    The introduction of a unit-dose medicines packing, distribution and administration system at University Hospital of Leicester has streamlined the work of nurses on the renal wards, according to senior nurses at the hospital.

  • The price of originator cancer drugs varies widely between high-income countries and the UK pays one of the lowest prices in Europe, according to research. In the image, a hospital pharmacist prepares chemotherapy drug for a cancer patient

    UK pays less than European neighbours for cancer drugs Subscription

    7 DEC 2015 16:43 By Ingrid Torjesen

    The price of originator cancer drugs varies widely between high-income countries and the UK pays one of the lowest prices in Europe.

  • Television advertisements for Nurofen Express in the UK are being investigated by the Advertising Standards Authority (ASA) following complaints that they were misleading. In the image, packs of Nurofen Express

    UK Nurofen advertisements under scrutiny after claims they are ‘misleading’ Subscription

    17 DEC 2015 13:19 By Debbie Andalo

    Nurofen Express advertisements are being investigated by the Advertising Standards Authority in the UK in response to complaints that they are misleading.

  • Treating diabetes patients requires more than drugs Subscription

    10 DEC 2015 13:02 By Monty Goldin

    Pharmacists must realise that type 2 diabetes is not just about glycaemic control. There is more to treating and preventing the condition than throwing pills at patients. Each branch of medicine is now involved in treating type 2 diabetes, including dietitians, dermatologists, podiatrists and even psychiatrists. Do we know the psycho-socioeconomic status of our diabetes patients? Do we understand the ominous octet and the mechanism of gluconeogenesis? It seems we have a lot to learn ...

  • Teratogenic effects with CellCept Subscription

    11 DEC 2015 10:53

    The summaries of product characteristics for CellCept (mycophenolate mofetil; Roche) now state that CellCept should not be inhaled or make direct contact with skin or mucous membranes because of teratogenic effects observed in rats. Additionally, warnings about use in pregnancy have been strengthened.

  • Second-generation antidepressants and cognitive behavioural therapy (CBT) are equally effective in patients with depression, researchers have found. In the image, a young girl talks to a therapist

    Talking therapies are just as effective as drugs in depression Subscription

    10 DEC 2015 13:40 By Kirsty Oswald

    Second-generation antidepressants and cognitive behavioural therapy are equally as effective in patients with depression, researchers have found.

  • Researchers suggest bypassing step two opioids, such as codeine, for cancer pain management in favour of step III opioids like low-dose morphine and oxycodone. In the image, light micrograph of oxycodone

    Study supports bypassing weak opioids for strong opioids in cancer pain Subscription

    22 DEC 2015 12:30

    Most patients given low-dose morphine, a strong opioid, achieved pain reduction of at least 20%, researchers find.

  • Technical problems being experienced by the online pharmacy company Pharmacy2U (P2U) have prompted NHS England to write to GPs and other primary care service providers to warn them about the “unacceptable” disruption to services.

    Service disruption at Pharmacy2U prompts action by NHS England and pharmacy regulator Subscription

    24 DEC 2015 11:26
    Comments (3)

    Technical problems being experienced by the online pharmacy company Pharmacy2U have prompted NHS England to write to GPs and other primary care service providers to warn them about the “unacceptable” disruption to services.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.